Drug Type Oncolytic virus |
Synonyms GC001溶瘤痘苗病毒, GC 001, GC-001 + [1] |
Target |
Action inhibitors |
Mechanism STRIP1 inhibitors(striatin interacting protein 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| High grade glioma | Phase 1 | China | 08 Oct 2024 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 26 Apr 2023 | |
| Breast Cancer | Phase 1 | China | 26 Apr 2023 | |
| Colonic Cancer | Phase 1 | China | 26 Apr 2023 | |
| Hepatocellular Carcinoma | Phase 1 | China | 26 Apr 2023 | |
| Lung Cancer | Phase 1 | China | 26 Apr 2023 | |
| Ovarian Cancer | Phase 1 | China | 26 Apr 2023 | |
| Pancreatic Cancer | Phase 1 | China | 26 Apr 2023 | |
| Sarcoma | Phase 1 | China | 26 Apr 2023 | |
| Stomach Cancer | Phase 1 | China | 26 Apr 2023 |





